Nancy Lurker
CIK 1450485 · Executive Vice Chair · last filed 2026-05-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$7.22M
Companies
8
Total Filings
90
Lifetime Open-Market Net
-$2.39M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALKS | Director | 18,222 | $44.28 | $806.9K | $0 | 7 | 2026-05-22 |
| COLL | Director | 26,758 | $34.64 | $926.9K | -$161.9K | 4 | 2026-05-18 |
| EYPT | Director | 421,235 | $13.03 | $5.49M | -$1.46M | 44 | 2026-01-07 |
| AQST | Director | — | $4.17 | — | $0 | 4 | 2021-06-17 |
| EyePoint, Inc. (PSDV) Delisted | President & CEO | 95,033 | — | — | $100.0K | 4 | 2018-03-21 |
| Keenova Therapeutics plc (MNK) Delisted | Director | 10,507 | $0.34 | $3.6K | $0 | 4 | 2016-03-18 |
| INTERPACE BIOSCIENCES, INC. (PDII) Delisted | CEO | 477,317 | — | — | $235.8K | 13 | 2015-03-09 |
| AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | Director | 0 | — | — | -$1.10M | 10 | 2015-01-30 |
Recent Filings · Page 5 of 9
90 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-03-02 | EYPT | Exer (M) | +12,467 | $0 | EDGAR |
| 2021-02-23 | EYPT | Exer (M) | +13,717 | $0 | EDGAR |
| 2020-07-02 | EYPT | Exer (M) | +124,667 | $0 | EDGAR |
| 2020-06-30 | EYPT | Exer (M) | +40,000 | $0 | EDGAR |
| 2020-06-18 | AQST | Grant (A) | — | $0 | EDGAR |
| 2020-06-16 | EYPT | Exer (M) | +45,000 | $0 | EDGAR |
| 2020-03-11 | EYPT | Buy (P) | +98,000 | $104.0K | EDGAR |
| 2020-03-03 | EYPT | Grant (A) | — | $0 | EDGAR |
| 2020-02-25 | EYPT | Exer (M) | +137,174 | $0 | EDGAR |
| 2019-10-15 | EYPT | Tax (F) | −10,745 | -$22.6K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.